Short answer
Becton Dickinson (BDX) filed an 8-K current report with the SEC on May 29, 2026 reporting Item 7.01 (Regulation FD Disclosure). U.S. ChloraPrep shipments resumed after additional final release testing.
Becton Dickinson 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- U.S. ChloraPrep shipments resumed after additional final release testing
- Testing completed to date acceptable, supporting restored product availability
- No patient safety signals reported, reducing immediate safety concerns
- PurPrep remains on U.S. ship hold, preserving regulatory and supply-chain risk
- FDA El Paso Warning Letter remains the underlying compliance issue for investors
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Becton Dickinson 8-K filings
Get the next BDX 8-K as it lands
Follow BDX for push alerts, or ask the research agent what this filing means.